LOWER GWYNEDD TWP., Pa. — Global healthcare giant Johnson & Johnson has announced plans to build a new $1 billion facility in Lower Gwynedd Township, marking a major investment in Montgomery County and further strengthening the region’s role as a hub for pharmaceutical and life sciences innovation.
The company confirmed the new facility will focus on advancing pharmaceutical manufacturing and research operations, supporting Johnson & Johnson’s ongoing efforts to expand production capacity and accelerate development of new treatments. The project is expected to create hundreds of construction jobs during development, followed by long-term permanent positions once the facility becomes operational.
Local and state officials have praised the investment, noting its potential economic impact across the region. In addition to direct employment opportunities, the new facility is expected to generate significant secondary economic benefits, including increased demand for local suppliers, contractors, and support services.
Johnson & Johnson already maintains a strong presence in southeastern Pennsylvania, with multiple facilities throughout Montgomery County and the greater Philadelphia area. The region is widely recognized as one of the nation’s leading pharmaceutical and biotechnology corridors, with major companies investing heavily in research, manufacturing, and innovation.
Company officials say the Lower Gwynedd facility will incorporate advanced technology and modern manufacturing processes designed to improve efficiency, support next-generation therapies, and meet growing global demand for pharmaceutical products.
Construction timelines and additional project details are expected to be released in the coming months as planning and permitting move forward.
The announcement represents one of the largest private investments in Montgomery County in recent years and reinforces Pennsylvania’s continued importance in the global healthcare and pharmaceutical industry.
